So, as we’ve discussed over the past few days (check yesterday’s blog, if you want), the FDA approved Aduhelm, the monoclonal antibody that attaches to amyloid. The problem is that there is no clinical data demonstrating this will help alleviate the memory loss in Alzheimer’s patients- despite the FDA approval.
Continue reading Alzheimers- but not Aduhelm
Now we know there is a link between our gut and Alzheimer’s disease, as we saw in yesterday’s post.
Continue reading A Blood Test?
This is just one study. And, a preliminary one. But…
A little background. I have often spent two or three days in a row working out the kinks in a design. Read that statement more correctly as 48 to 70 hours non-stop. No sleep.
Continue reading Pulling an Allnighter Just Got a Little More Complicated
OK. It’s bogeyman time.
Alzheimer’s! Yes. Even more than cancer- this word scares the bejesus out of us.
Continue reading Early. Onset.
